Intech Biopharm Corporation (TPEX: 6461)

Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	78.88	77.73	64.82	220.48	204.69	172.12
Short-Term Investments	255	520	310	115	100	105
Cash & Short-Term Investments	333.88	597.73	374.82	335.48	304.69	277.12
Cash Growth	10.94%	59.47%	11.73%	10.11%	9.95%	115.90%
Accounts Receivable	1.83	3.05	3.67	15.04	4.87	3.59
Other Receivables	9.91	8.7	7.94	7.94	7.78	9.06
Receivables	11.74	11.74	11.6	22.98	12.65	12.65
Inventory	60.01	41.53	51.82	59.87	56.97	44.42
Prepaid Expenses	71.58	43.62	40.7	33.74	35.46	26.04
Other Current Assets	0.11	0.41	0.13	4.26	-	-
Total Current Assets	477.31	695.02	479.06	456.33	409.77	360.22
Property, Plant & Equipment	1,873	1,900	2,009	2,090	2,178	2,204
Other Intangible Assets	4.12	4.88	4.8	4.62	4.75	4.95
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	88.82	86.15	33.17	26.26	4.31	12.15
Total Assets	2,468	2,711	2,551	2,602	2,621	2,606
Accounts Payable	4.84	0.31	1.33	2.4	1.02	0.39
Accrued Expenses	26.86	19.24	23.71	20.82	19.56	18.36
Short-Term Debt	-	-	-	-	30	-
Current Portion of Long-Term Debt	249.41	464.65	265.26	211.66	12.89	99.35
Current Unearned Revenue	78.31	78.54	78.31	78.99	81.21	81.38
Other Current Liabilities	5.35	5.99	5.23	9.35	9.86	7.51
Total Current Liabilities	364.76	568.73	373.82	323.22	154.52	206.99
Long-Term Debt	1,188	970.41	1,143	940.77	1,138	829.63
Long-Term Unearned Revenue	5.53	2.35	-	-	-	-
Other Long-Term Liabilities	1.72	1.74	1.54	-	-	-
Total Liabilities	1,560	1,543	1,519	1,264	1,293	1,037
Common Stock	1,374	1,374	1,170	1,163	1,007	1,005
Additional Paid-In Capital	9.83	286.16	195.15	481.32	574.58	877.29
Retained Earnings	-475.06	-488.08	-327.88	-301.76	-250.37	-311.42
Comprehensive Income & Other	-	-4.32	-5.13	-4.72	-2.7	-1.78
Shareholders' Equity	908.82	1,168	1,032	1,338	1,329	1,569
Total Liabilities & Equity	2,468	2,711	2,551	2,602	2,621	2,606
Total Debt	1,437	1,435	1,409	1,152	1,181	928.99
Net Cash (Debt)	-1,103	-837.33	-1,034	-816.94	-876.4	-651.87
Net Cash Per Share	-8.12	-6.95	-8.90	-8.03	-8.74	-7.99
Filing Date Shares Outstanding	137.41	137.41	116.96	116.28	100.73	100.49
Total Common Shares Outstanding	137.41	137.41	116.96	116.28	100.73	100.49
Working Capital	112.55	126.3	105.24	133.11	255.25	153.23
Book Value Per Share	6.61	8.50	8.82	11.50	13.19	15.61
Tangible Book Value	904.7	1,163	1,027	1,333	1,324	1,564
Tangible Book Value Per Share	6.58	8.46	8.78	11.46	13.14	15.56
Land	919.87	919.87	950.72	950.72	950.72	950.72
Buildings	790.42	790.24	798.32	810.2	809.13	769.28
Machinery	693.54	657.12	645.9	633.52	616.6	597.39

Source: S&P Capital IQ. Standard template. Financial Sources.